LUCY LIAO: Open Payments
NPI 1649724386 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,073 in 74 payments from 11 companies in 2025. Trend: 2023 $1,911 · 2024 $2,568 · 2025 $2,073
Food & beverage: $2,073
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $897 |
| ABBVIE INC. | 28 | $509 |
| Novo Nordisk Inc | 4 | $217 |
| Ardelyx, Inc. | 9 | $145 |
| Gilead Sciences, Inc. | 3 | $87 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| Lilly USA, LLC | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: EVENITY, Ozempic, LINZESS, UBRELVY, QULIPTA, IBSRELA, OTEZLA, NEXLETOL.
Industry payments across NY — which companies pay providers there.
